Should I use Mitotane or chemotherapy after surgery for adrenocortical cancer?

Adrenocortical carcinoma (Adrenocortical Carcinoma,ACC) is a rare but aggressive cancer that often requires comprehensive treatment strategies to manage. Postoperative care is an important part of treatment for ACC, and when choosing a treatment, doctors typically consider a range of factors, including surgical feasibility, tumor stage and the patient's overall health. Mitotane and chemotherapy are both options for postoperative treatment, but they may be more appropriate in different situations.

Mitotan’s role:

Mitotan is a hormone disruptor used primarily to treat adrenocortical cancer, particularly in patients who have had surgery to remove the tumor. Here is the role of mitotane in postoperative care:

1.Postoperative adjuvant treatment: For ACC patients, surgery is usually the first choice of treatment, especially when the cancer has not spread to other locations. However, in some cases, surgery cannot completely remove the tumor, or the tumor has spread to other tissues. In this setting, mitotane is often used as part of postoperative adjuvant therapy to reduce the risk of tumor recurrence.

2.Reduce the risk of recurrence: Mitotane can reduce the risk of recurrence of adrenocortical cancer. By inhibiting the growth of tumor cells and controlling the secretion of adrenocortical hormones, it helps maintain a stable state of the disease and reduces the possibility of tumor growth again.

3.Control symptoms: Mitotan can also reduce symptoms related to adrenocortical cancer, such as high blood pressure, mood swings, obesity, etc. This is important to improve patients' quality of life.

The role of chemotherapy:

Chemotherapy is often used in the treatment of adrenocortical cancer when:

1.Advanced disease: For those whose tumors have spread to other tissues or organs, surgical removal usually does not cure the disease completely. In this case, chemotherapy may be used to control tumor growth and reduce symptoms. Chemotherapy drugs may include mitoxantrone (Mitoxantrone) and cisplatin (Cisplatin).

2.Recurrence: If adrenocortical cancer recurs after surgery, or has spread to other areas before surgery, chemotherapy may be a treatment option. This helps prolong survival and improve patients' quality of life.

3.Chemotherapy combination therapy: In some cases, doctors may choose to use chemotherapy with mitotane to increase the effectiveness of the treatment. This combined treatment approach may be more beneficial to patients in certain circumstances.

Decision Factors:

When choosing post-operative treatment, doctors typically consider the following factors:

1.Surgical feasibility: Whether the tumor can be completely removed is a key factor. If surgery is able to completely remove the tumor, postoperative adjuvant therapy usually includes mitotane. If surgery is incomplete or not feasible, chemotherapy may be more appropriate.

2.Staging and grading: The stage and grade of adrenocortical cancer can also affect treatment options. Advanced and high-grade tumors may require more aggressive treatment, including chemotherapy.

3.Patient health: The patient's overall health and drug tolerance are also factors in the decision-making. Some patients may be more tolerant to chemotherapy drugs, while others may be better candidates for mitotane.

Ultimately, treatment decisions should be made by a professional medical team taking into account the patient's individual situation and tumor characteristics. Communication between patient and doctor is crucial to ensure a treatment plan that is best for the patient. Whether with mitotane, chemotherapy, or a combination, the goals of treatment are to improve patient survival, reduce symptoms, and improve quality of life.

Mitotane has not yet been launched in China, so patients cannot purchase it domestically and need to purchase it through overseas channels. There are original drugs and generic drugs abroad. The Turkish version of the original drug is about more than 7,000 yuan, followed by the European version of the original drug, which is about 9,000 yuan. There are also cost-effective generic drugs, mainly Laos and ASEAN generic drugs. The price is about more than 3,000 yuan. The ingredients of the original drugs and generic drugs are the same.